Sograzepide CAS No.155488-25-8
Sograzepide CAS No.155488-25-8
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-4222 | 5mg | 360.00 | + Add to cart |
|
| R-R-4222 | 10mg | 630.00 | + Add to cart |
|
|
|
||||
Product description
Sograzepide (Netazepide; YF 476; YM-220)/CAS No.155488-25-8 is an extremely potent , highly selective and orally active Gastrin/CCK-B antagonist with an IC50 value of 0.1 nM, has inhibitory effect on Gastrin/CCK-A activity with an IC50 of 502 nM. Sograzepide (Netazepide; YF 476; YM-220) replaces the specific binding of [125I]CCK-8 to the rat brain, cloned canine and cloned human Gastrin/CCK-B receptors, with Ki values of 0.068, 0.62 and 0.19 nM, respectively.
| Appearance | N/A |
|---|---|
| Molecular Weight | 498.58 |
| Purity | >90% |
| CAS | 155488-25-8 |
| Formula | C28H30N6O3 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Sograzepide CAS No.155488-25-8
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


